Onconetix (ONCO) Stock: Buy, Sell, or Hold?
$3.76
+0.29 (+8.36%)
▲
5d:
+471.17%
30d:
+577.48%
90d:
+326.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
31/100
Position
EXTENDED
30-Day Fair Range
$-0.42 – $2.22
Position: EXTENDED
Wall Street Target
$9.00
+139.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.50 / $7.82
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: ONCO is 69.4% above its trading range ($2.22). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When ONCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ONCO is currently trading at $3.76, which is considered extended relative to its 30-day fair value range of $-0.42 to $2.22.
Technical Outlook: Technically, ONCO is showing sideways momentum. Immediate support is located at $0.50, while resistance sits at $7.82. The stock is showing strong short-term momentum, up 8.4% recently.
Market Sentiment: ONCO scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.00 (+139.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ONCO is showing sideways momentum. Immediate support is located at $0.50, while resistance sits at $7.82. The stock is showing strong short-term momentum, up 8.4% recently.
Market Sentiment: ONCO scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.00 (+139.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.42 -
$2.22
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$-0.42 -
$2.22
Current vs Trading Range
EXTENDED
Support Level
$0.50
Resistance Level
$7.82
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+69.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.4%)
- BULLISH: Trading 139.4% below Wall St target ($9.00)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$9.00
(+139.4%)
Revenue Growth (YoY)
-83.9%
Share ONCO Analysis
Share this live ONCO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ONCO)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Realbotix extends merger with Onconetix to March 31, 2027, with no minimum net cash closing condition.
Key Retail Themes:
Merger extension
Commitment to closing the deal
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:45 PM ET
Data refreshes hourly during market hours. Next update: 9:45 PM
Data refreshes hourly during market hours. Next update: 9:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ONCO Research Pages
